Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_31544 | 54 | 1.13 | Mlig455_019284 | Neo: - Age: Up-Down-Up |
Mlig455_019284 {REF} {Length: 2664} {RNA1509_26962} {RNA1310_7663} {RNA815_9340} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.449 | 1.469 | 0.42874 | 1.00000 | |
RegionR2 | 1.857 | 1.469 | 0.26773 | 0.65068 | |
RegionR3 | 1.394 | 1.469 | 0.31695 | 0.85579 | |
RegionR4 | -1.082 | 1.469 | 0.99321 | 1.00000 | |
RegionR5 | -0.736 | 1.469 | 0.98010 | 1.00000 | |
RegionR6 | 0.477 | 1.469 | 0.71357 | 1.00000 | |
RegionR7 | 2.124 | 1.469 | 0.17566 | 0.76916 | |
RegionR8 | 0.416 | 1.469 | 0.81414 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.588 | 1.469 | 0.99997 | 1.00000 | |
RegenerationR2 | -1.086 | 1.469 | 0.32530 | 0.76356 | |
RegenerationR3 | -0.65 | 1.469 | 0.55606 | 0.88665 | |
RegenerationR4 | -1.13 | 1.469 | 0.36441 | 0.78986 | |
RegenerationR5 | -0.766 | 1.469 | 0.52257 | 0.87079 | |
RegenerationR6 | -0.559 | 1.469 | 0.64525 | 0.89608 | |
RegenerationBL | -1.221 | 1.469 | 0.53253 | 0.89235 | |
RegenerationTP | -4.932 | 1.469 | 0.09841 | 0.49004 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_31544 | 54 | 1.13 | Mlig455_019284 | Neo: - Age: Up-Down-Up |
3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_019284 {REF} {Length: 2664} {RNA1509_26962} {RNA1310_7663} {RNA815_9340} | |
2. | MligTC455_44220 | 119 | 2.49 | Mlig455_053870 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.322 Region-enriched R8: 4.672/0.00316 Regeneration-depleted BL: -8.794 |
CDH23 | 0.988 | - | - | 0.988 | - | - | - | Mlig455_053870 {REF} {Length: 7139} {Pfam: Cadherin domain [PF00028.19, score=356.1]; Cadherin-like [PF08266.14, score=28.2]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=370, Expect=4e-103]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=372, Expect=6e-104]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [Score=434, Expect=2e-124]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=240, Expect=2e-63]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=522, Expect=3e-155]} {RNA1509_44173, RNA1509_9298} {RNA1310_449.1, RNA1509_44173} {RNA1509_44173, RNA815_181} |
3. | MligTC455_13815 | 35 | 0.73 | Mlig455_064174 | Neo: - Age: - |
PCSK4 | 0.978 | - | - | - | 0.978 | - | - | Mlig455_064174 {REF} {Length: 3017} {Pfam: Subtilase family [PF00082.24, score=158.9]; Proprotein convertase P-domain [PF01483.22, score=79.8]; Peptidase S8 pro-domain [PF16470.7, score=55.6]} {Human: ENSG00000115257, PCSK4, proprotein convertase subtilisin/kexin type 4, [RH, Score=501, Expect=2e-168]} {Mouse: ENSMUSG00000020131, Pcsk4, proprotein convertase subtilisin/kexin type 4, [RH, Score=501, Expect=3e-170]} {Dmel: FBgn0004509, Fur1, Furin 1, [Score=508, Expect=4e-170]} {Celegans: WBGene00002232, kpc-1, Furin-like protease kpc-1, [Score=522, Expect=6e-178]} {Smed: dd_Smed_v6_10832_0_1, dd_Smed_v6_10832_0_1, [Score=535, Expect=0.0]} {RNA1310_67050} {RNA815_18475} |
4. | MligTC455_02589 | 124 | 2.59 | Mlig455_027271 | Neo: - |
MX1 | 0.971 | - | - | 0.971 | - | - | - | Mlig455_027271 {REF} {Length: 4609} {Pfam: Dynamin central region [PF01031.22, score=152.2]; Dynamin GTPase effector domain [PF02212.20, score=57.4]; Family with sequence similarity 184, A and B [PF15665.7, score=20.6]} {Human: ENSG00000157601, MX1, MX dynamin like GTPase 1, [Score=136, Expect=2e-34]; ENSG00000183486, MX2, MX dynamin like GTPase 2, [Score=132, Expect=4e-33]} {Mouse: ENSMUSG00000023341, Mx2, MX dynamin-like GTPase 2, [Score=144, Expect=3e-37]} {RNA1509_19894, RNA1509_52436, RNA1509_54554, RNA1509_8812} {RNA1310_1482.2, RNA1509_19894, RNA1509_52436, RNA1509_54554, RNA1509_8812} {RNA1509_19894, RNA1509_52436, RNA1509_54554, RNA1509_8812, RNA815_3194} |
5. | MligTC455_48647 | 99 | 2.07 | Mlig455_053994 | Neo: - Age: - |
ASIC5 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_053994 {REF} {Length: 2559} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=165.2]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=53.1, Expect=1e-06]; ENSG00000262505, AC093830.1, acid sensing ion channel subunit family member 5, [Score=53.1, Expect=9e-07]; ENSG00000213199, ASIC3, acid sensing ion channel subunit 3, [Score=52.8, Expect=1e-06]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=56.2, Expect=9e-08]; ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=63.2, Expect=3e-10]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=79.3, Expect=2e-15]} {RNA1509_35422} {RNA1310_9082.1} {RNA815_4853} |
6. | MligTC455_11604 | 23 | 0.48 | Mlig455_051147 | Neo: - Age: - |
0.962 | - | - | - | 0.962 | - | - | Mlig455_051147 {REF} {Length: 204} {NoTransDecoderORF} {RNA1310_26391} {RNA815_5978} | |
7. | MligTC455_18092 | 35 | 0.72 | Mlig455_014741 | Neo: - Age: - |
ARL3 | 0.961 | - | - | - | 0.961 | - | - | Mlig455_014741 {REF} {Length: 1753} {Pfam: ADP-ribosylation factor family [PF00025.23, score=67.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.6]; G-protein alpha subunit [PF00503.22, score=19.1]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=67.8, Expect=2e-13]; ENSG00000122644, ARL4A, ADP ribosylation factor like GTPase 4A, [Score=67.8, Expect=3e-13]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSG00000168374, ARF4, ADP ribosylation factor 4, [Score=65.1, Expect=2e-12]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=65.1, Expect=2e-12]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=64.7, Expect=4e-12]} {Mouse: ENSMUSG00000047446, Arl4a, ADP-ribosylation factor-like 4A, [Score=67.4, Expect=2e-13]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=66.6, Expect=4e-13]; ENSMUSG00000048076, Arf1, ADP-ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSMUSG00000051853, Arf3, ADP-ribosylation factor 3, [Score=65.1, Expect=1e-12]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=64.3, Expect=3e-12]} {Dmel: FBgn0013749, Arf102F, ADP ribosylation factor at 102F, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00000184, arf-6, ADP-Ribosylation Factor related, [Score=65.5, Expect=5e-13]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=78.6, Expect=7e-18]} {RNA1310_41790} {RNA815_35492} |
8. | MligTC455_28294 | 127 | 2.64 | Mlig455_006642 | Neo: - Age: Up-Down-Up |
ANKRD17 | 0.96 | - | - | - | 0.960 | - | - | Mlig455_006642 {REF} {Length: 7026} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=380.4]; Ankyrin repeats (many copies) [PF13637.8, score=222.9]; Ankyrin repeat [PF13606.8, score=165.6]; Ankyrin repeats (many copies) [PF13857.8, score=142.3]; Ankyrin repeat [PF00023.32, score=136.2]; Nucleotide-Binding Domain 94 of RH [PF16830.7, score=23.4]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=139, Expect=7e-32]} {Mouse: ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=139, Expect=3e-32]} {Dmel: FBgn0039590, CG10011, [Score=90.5, Expect=1e-17]} {Celegans: WBGene00012124, T28D6.4, [Score=84.7, Expect=5e-16]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=106, Expect=9e-23]} {RNA1509_44391} {RNA1310_30754} {RNA815_10474.1} |
9. | MligTC455_09131 | 12 | 0.25 | Mlig455_060831 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_060831 {REF} {Length: 222} {NoTransDecoderORF} {RNA1509_37730} {RNA1310_49631.1} {RNA815_12906} | |
10. | MligTC455_52290 | 54 | 1.12 | Mlig455_000596, Mlig455_030333 | Neo: - Age: - |
SCNN1A | 0.957 | - | - | - | 0.957 | - | - | Mlig455_000596 {REF} {Length: 2088} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=165.8]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=50.8, Expect=4e-06]} {Smed: dd_Smed_v6_20466_0_1, dd_Smed_v6_20466_0_1, [RH, Score=404, Expect=1e-133]} {RNA1310_20263} {RNA815_20553} Mlig455_030333 {REF} {Length: 2092} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=111.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=57.4, Expect=2e-08]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=53.5, Expect=3e-07]} {Smed: dd_Smed_v6_20466_0_1, dd_Smed_v6_20466_0_1, [Score=279, Expect=2e-88]} {RNA1310_20263} {RNA815_20553} |
11. | MligTC455_08037 | 13 | 0.27 | Mlig455_037418, Mlig455_037484 | Neo: - Age: - |
CHRNB2, HTR3E | 0.955 | - | - | 0.955 | - | - | - | Mlig455_037418 {REF} {Length: 1268} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=102.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.2]} {Human: ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=129, Expect=3e-32]; ENSG00000186038, HTR3E, 5-hydroxytryptamine receptor 3E, [Score=128, Expect=3e-32]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=2e-31]; ENSG00000178084, HTR3C, 5-hydroxytryptamine receptor 3C, [Score=126, Expect=2e-31]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=125, Expect=4e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=124, Expect=7e-31]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=123, Expect=3e-30]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=130, Expect=5e-33]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=127, Expect=6e-32]; ENSMUSG00000041189, Chrnb1, cholinergic receptor, nicotinic, beta polypeptide 1 (muscle), [Score=124, Expect=1e-30]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=137, Expect=3e-35]} {Celegans: WBGene00017580, lgc-4, Ligand-gated ion channel 4, [Score=142, Expect=1e-36]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=134, Expect=2e-34]} {RNA1509_53098} {RNA1310_100091} {RNA815_45198} Mlig455_037484 {REF} {Length: 1840} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.2]} {Human: ENSG00000186038, HTR3E, 5-hydroxytryptamine receptor 3E, [Score=129, Expect=9e-33]; ENSG00000178084, HTR3C, 5-hydroxytryptamine receptor 3C, [Score=127, Expect=7e-32]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=127, Expect=7e-32]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=1e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=125, Expect=4e-31]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=125, Expect=9e-31]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=130, Expect=4e-33]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=127, Expect=1e-31]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=135, Expect=1e-34]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=137, Expect=5e-36]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=130, Expect=2e-33]} {RNA1509_53098} {RNA1310_100091} {RNA815_45198} |
12. | MligTC455_14009 | 6 | 0.12 | Mlig455_059593 | Neo: - Age: - |
0.952 | - | - | - | 0.952 | - | - | Mlig455_059593 {REF} {Length: 242} {NoTransDecoderORF} {RNA1509_47234} {RNA1310_54132} {RNA815_14343.2} |